Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

Previous studies have shown that an epidermal growth factor‐based formulation (Heberprot‐P) can enhance granulation of high‐grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to complete wound closure. A pilot study in 20 diabetic pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int Wound J
Egile Nagusiak: Fernández‐Montequín, José I, Betancourt, Blas Y, Leyva‐Gonzalez, Gisselle, Mola, Ernesto L, Galán‐Naranjo, Katia, Ramírez‐Navas, Mayte, Bermúdez‐Rojas, Sergio, Rosales, Felix, García‐Iglesias, Elizeth, Berlanga‐Acosta, Jorge, Silva‐Rodriguez, Ricardo, Garcia‐Siverio, Marianela, Martinez, Luis H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2009
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951202/
https://ncbi.nlm.nih.gov/pubmed/19291119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2008.00561.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak